BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10565747)

  • 1. Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen.
    Lechevallier E; Eghazarian C; Ortega JC; Roux F; Coulange C
    Urology; 1999 Nov; 54(5):857-61. PubMed ID: 10565747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.
    Richie JP; Catalona WJ; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; deKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
    Urology; 1993 Oct; 42(4):365-74. PubMed ID: 7692657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The percentage of free prostatic-specific antigen is also useful in men with normal digital rectal examination and serum prostatic-specific antigen between 10.1 and 20 ng/ml.
    Morote J; Trilla E; Esquena S; Serrallach F; Abascal JM; Muñoz A; Id M'Hammed Y; de Torres IM
    Eur Urol; 2002 Oct; 42(4):333-7. PubMed ID: 12361897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice.
    Collins GN; Martin PJ; Wynn-Davies A; Brooman PJ; O'Reilly PH
    J Urol; 1997 May; 157(5):1744-7. PubMed ID: 9112518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
    Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer.
    Okihara K; Cheli CD; Partin AW; Fritche HA; Chan DW; Sokoll LJ; Brawer MK; Schwartz MK; Vessella RL; Loughlin KR; Johnston DA; Babaian RJ
    J Urol; 2002 May; 167(5):2017-23; discussion 2023-4. PubMed ID: 11956430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of free/total prostate specific antigen (f/t PSA) ratio in diagnosis of prostate carcinoma.
    Thakur V; Singh PP; Talwar M; Mukherjee U
    Dis Markers; 2003-2004; 19(6):287-92. PubMed ID: 15258330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.
    Ornstein DK; Rao GS; Smith DS; Ratliff TL; Basler JW; Catalona WJ
    J Urol; 1997 Jan; 157(1):195-8. PubMed ID: 8976249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml.
    Okihara K; Fritsche HA; Ayala A; Johnston DA; Allard WJ; Babaian RJ
    J Urol; 2001 Jun; 165(6 Pt 1):1930-6. PubMed ID: 11371884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model.
    Catalona WJ; Partin AW; Finlay JA; Chan DW; Rittenhouse HG; Wolfert RL; Woodrum DL
    Urology; 1999 Aug; 54(2):220-4. PubMed ID: 10443714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristics.
    Guthman DA; Wilson TM; Blute ML; Bergstralh EJ; Zincke H; Oesterling JE
    Urology; 1993 Aug; 42(2):150-4. PubMed ID: 7690170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effect of digital rectal examination on serum prostate-specific antigen levels. A prospective study.
    Cevik I; Türkeri LN; Ozveri H; Ilker Y; Akdaş A
    Eur Urol; 1996; 29(4):403-6. PubMed ID: 8791045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network.
    Finne P; Finne R; Auvinen A; Juusela H; Aro J; Määttänen L; Hakama M; Rannikko S; Tammela TL; Stenman U
    Urology; 2000 Sep; 56(3):418-22. PubMed ID: 10962306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of digital rectal examination on serum prostate-specific antigen in a primary care setting. The Internal Medicine Clinic Research Consortium.
    Arch Intern Med; 1995 Feb; 155(4):389-92. PubMed ID: 7531426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):773-8. PubMed ID: 7502414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination.
    Morote J; Raventós CX; Lorente JA; Enbabo G; López M; de Torres I
    Eur Urol; 1999 Aug; 36(2):111-5. PubMed ID: 10420031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.